Macular Chats

Ever wonder how Macular Degeneration Research identifies and supports the most promising scientific studies around the world? We recently awarded $3.8 million to researchers advancing bold ideas to better understand, prevent, and treat macular degeneration. In this episode of Macular Chats, Dr. Diane Bovenkamp highlights several of this year’s groundbreaking projects and explain how they’re driving progress in early detection, risk reduction, new treatments—and ultimately, a cure.

Can a simple vitamin or supplement help protect your sight? In this Macular Chats episode, we explore what current science tells us about nutritional approaches to support eye health, particularly in the context of age-related changes in the retina. Join Dr. Brian McKay and Dr. Murray Brilliant for a conversation about the widely used AREDS2 nutrient formula, as well as exciting new research into L-DOPA, a naturally occurring compound that may offer a stronger role for maintaining retinal health.

This Mental Health Awareness Month, join psychologist Ed McDaniel for an honest conversation about the emotional impact of being diagnosed with age-related macular degeneration (AMD) and/or geographic atrophy (GA). Drawing from both his professional expertise and personal experience, Ed will share strategies for coping with anxiety, grief, and loss of independence—and how to start important conversations about mental health with your eye doctor. Learn about resources that can help you feel less alone.

Join us for a special discussion on clinical trials for macular degeneration. Experts from Genentech will provide an overview of the company’s work in age-related macular degeneration (AMD) and geographic atrophy, including the role of clinical trials and how they work. They will also share details about an upcoming clinical trial for geographic atrophy, an advanced form of dry AMD, and what potential participants can expect.

Join us for a conversation about light therapy and macular degeneration, where we’ll explore how different types of light—blue, red, and sunlight—affect the retina, the science behind light therapy, and the newly approved Valeda red light therapy. Plus, we’ll answer listener questions about seasonal affective disorder (SAD) lights, red light therapy for early-stage AMD, and more. Bring your questions to ask our guest expert!

With two FDA-approved treatments now available for geographic atrophy, an advanced form of dry age-related macular degeneration, we’ll explore how to navigate treatment options, engage in shared decision-making with your healthcare team, and maximize your eye health. February is Low Vision Awareness Month, so we’ll also discuss support options for those living with vision loss.

Join us for an in-depth discussion on the latest developments in wet age-related macular degeneration treatment. We’re partnering with the American Society of Retina Specialists (ASRS) to bring you an overview of current treatment options, the impact of the Avastin shortage, and alternative treatments. We will also explore advocacy efforts by ASRS and the American Academy of Ophthalmology to address these issues.

This Macular Chat episode will cover practical tips for maintaining quality of life with low vision. From adaptive activities to resources like large print books, there are resources to help you live well.

Geographic atrophy is an advanced and severe form of dry age-related macular degeneration that, if left untreated, can lead to irreversible vision loss. Hear from guest expert Dr. Veeral Sheth about the latest treatments, research breakthroughs, and how to protect your vision.

Join us for an in-depth discussion on Stargardt disease, a rare inherited form of juvenile macular degeneration that affects about 1 in 10,000 children and young adults. Learn about the latest in diagnosis, genetic testing, and promising treatments, which researchers are also evaluating in geographic atrophy.